Real-World Insight That Moves Diabetes Research Forward

We help industry, academic, and advocacy partners move faster and with confidence by turning real-world data into actionable evidence.

Explore Partnership Opportunities
Woman with computer graphs in front of her checking glucose
Deep ExpertiseIn type 1 diabetes research
Robust DataAccess to real-world data
Trusted PartnerNonprofit collaborator across the ecosystem

Research That Moves From Insight to Implementation

T1D Exchange partners with industry, academia, advocacy organizations, and other researchers to design, deploy, analyze, and report on various types of diabetes research. 

From custom research and clinical study recruitment to targeted quality improvement initiatives, we help translate data into decisions that move diabetes innovation forward. 

Custom Research

  • Design studies that answer the right questions.
  • Execute research data collection and analysis.
  • Integrate participant-reported outcomes with clinical and device data. 
  • Synthesize report findings into meaningful insights.
Bring Your Research Project to Life
Focus Group

Research Study Recruitment

  • Recruit faster — without compromising quality. 
  • Access the T1D Exchange Online Registry.
  • Connect to interested individuals who meet study criteria.
  • Conduct a wide variety of research projects, including survey, focus groups and in-person studies. 
Discuss Recruitment Support
Group of adults with hands raised

Quality Improvement Initiatives

  • Support evidence-informed change at scale by partnering with T1DX-QI centers. 
  • Connect with one of the largest learning networks of healthcare providers.  
  • Utilize real-world insight.
  • Deploy standardized evidence-based QI methods.
Explore a Partnership with the T1DX-QI
iStock-2183476270

Turn Real-World Insight Into Measurable Change

The T1DX-QI offers research partners a unique opportunity to support measurable improvements in diabetes care while generating real-world insight. 

 

Through the collaborative, endocrinology centers across the U.S. securely contribute de-identified electronic health record data to a centralized platform. This shared data is analyzed, allowing centers to benchmark performance and identify opportunities for improvement. 

 

For research partners, this environment creates a powerful setting to evaluate how new technologies, tools, and care strategies perform in everyday clinical settings. 

 

By partnering on targeted quality improvement initiatives, organizations can help accelerate the adoption of effective practices while learning how innovations translate into real-world care. 

"We are incredibly grateful to partner with T1D Exchange across several research projects. Partnering with the T1D Exchange allowed us to include the perspectives of individuals with type 1 diabetes across the U.S. to inform our understanding of diabetes distress. "

~

University of California, San Francisco

Latest Publications

Type 1 Diabetes Screening
Early Detection

Type 1 Diabetes Screening: Early Detection & What's Next

Dr. Kimber Simmons on Early Detection, Screening, and the Future of Type 1 Diabetes What if you could know your risk for type 1 diabetes (T1D) years before symptoms appear — and have the opportunity to delay its progression? As researchers continue to advance early detection of T1D autoantibodies and disease-modifying therapies, a fundamental shift is underway that could change the lives of those most at risk.

Read more
Caitlin McGuillicuddy
Helmsley Charitable Trust

Meet The Diabetes Link's New COO, Caitlin McGillicuddy

The Diabetes Link is entering a new phase of growth, backed by a $1.5 million grant from The Leona M. and Harry B. Helmsley Charitable Trust, with a focus on reaching and supporting more young adults with diabetes, finding them not only in colleges, but also at community colleges, trade schools, and other youth organizations.

Read more
Beyond A1C: Why Time in Range Matters for T1D
Community

Beyond A1C: Why Time in Range Matters for T1D

For decades, hemoglobin A1C (A1C) has been the gold standard for assessing diabetes management. Estimating average blood glucose over the past two to three months, it has long guided treatment decisions for people with diabetes.

Read more

Explore Partnership Opportunities

Ready to move your diabetes research forward? Let's start a conversation. 
Get in Touch